Vanguard Group »

Mink Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $251k 234k 1.07
2023-09-30 $258k 234k 1.10
2023-06-30 $507k 241k 2.10
2023-03-31 $93k 49k 1.90
2022-12-31 $128k 49k 2.61
2022-03-31 $23k 10k 2.22